Lynnie Lin Trzoss

This inventor holds 18 USPTO granted patents and 9 published patent applications and 1 EPO patent. Top assignees: Xinthera, Inc., Genentech, Inc., Celgene Quanticel Research, Inc.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lynnie Lin Trzoss. Retrieved from https://idiyas.com/inventor/lynnie-lin-trzoss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 (Patent Applications = 9)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 14)

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 25(Granted Patents)

Location History:

South San Francisco, CA (US) (2023)
San Diego, CA (US) (2016 - 2024)

Company Filing History:

Celgene Quanticel Research, Inc.

University of California

patents

Years Active: 2016-2026

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12545662 - MK2 inhibitors and uses thereof (2026-02-10),

2. 12410179 - Modulators of TNF alpha activity and uses thereof (2025-09-09),

3. 12384780 - PARP1 inhibitors and uses thereof (2025-08-12),

4. 12234245 - Sulfonimidamide compounds as inhibitors of interleukin-1 activity (2025-02-25),

5. 12139462 - Pyridinone MK2 inhibitors and uses thereof (2024-11-12),

6. 11987574 - MK2 inhibitors and uses thereof (2024-05-21),

7. 11939329 - PARP1 inhibitors and uses thereof (2024-03-26),

8. 11890275 - Therapeutic compounds (2024-02-06),

9. 11802128 - Azetidine and pyrrolidine PARP1 inhibitors and uses thereof (2023-10-31),

10. 11702428 - Chemical compounds as inhibitors of interleukin-1 activity (2023-07-18),

11. 11685719 - Pyridinone MK2 inhibitors and uses thereof (2023-06-27),

12. 11680056 - MK2 inhibitors and uses thereof (2023-06-20),

13. 11591331 - PARP1 inhibitors and uses thereof (2023-02-28),

14. 11560391 - Sulfonylurea compounds as inhibitors of interleukin-1 activity (2023-01-24),

15. 11040985 - Chemical compounds as inhibitors of interleukin-1 activity (2021-06-22),

Title: The Innovative Journey of Lynnie Lin Trzoss

Introduction: Lynnie Lin Trzoss is a pioneering inventor based in San Diego, CA, known for her groundbreaking contributions to the field of biotechnology.

Latest Patents: Lynnie Lin Trzoss holds several patents in the biotech sector, including a recent patent for a novel drug delivery system that has the potential to revolutionize targeted therapies.

Career Highlights: With a background in biochemistry and pharmaceuticals, Lynnie Lin Trzoss has had a distinguished career marked by a series of innovative discoveries. Her work has been instrumental in advancing the development of new treatments for various diseases.

Collaborations: Throughout her career, Lynnie Lin Trzoss has collaborated with leading researchers, scientists, and pharmaceutical companies to bring her inventions to life. Her collaborative spirit has been key to the success of many projects.

Conclusion: Lynnie Lin Trzoss continues to be a driving force in the world of biotechnology, with her passion for innovation and dedication to improving healthcare making her a standout figure in the field.

Profile summary based on public USPTO records.